California Public Employees Retirement System Protalix Bio Therapeutics, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$1.86 - $6.22 $123,933 - $414,444	-66,631 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$2.1 - $4.61 $28,263 - $62,045	-13,459 Reduced 16.8%	66,631 $157,000
Q4 2019 Jan 27, 2020	BUY	$1.8 - $3.28 $144,162 - $262,695	80,090 New	80,090 $263,000

Others Institutions Holding PLX

# of Institutions

Shares Held

3.58M

Call Options Held

61.1K

Put Options Held

36.2K

Jim Simons Renaissance Technologies LLC | New York, Ny

956K
Shares

$1.67 Million
0.0% of portfolio
Gsa Capital Partners LLP London, X0

435K
Shares

$761,622
0.03% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

374K
Shares

$654,074
0.0% of portfolio
Black Rock Inc. New York, NY

333K
Shares

$583,049
0.0% of portfolio
Stratos Wealth Partners, Ltd.

270K
Shares

$472,500
0.0% of portfolio

View Full List

About Protalix BioTherapeutics, Inc.

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $87.1M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

More about PLX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account